During a medical procedure, a transseptal fenestration is made at a septum of the heart and a shunt is implanted into the transseptal fenestration. During the same medical procedure, a transapical puncture is made into a left ventricle of the heart. A prosthetic valve is delivered via the transapical puncture and implanted at a mitral valve of the heart. Subsequently to delivering the prosthetic valve and making the transseptal fenestration, the transapical puncture is closed. Other embodiments are also described.

A method and system of bending medical device components for customization to a particular medical procedure and patient while generally maintaining the ideal performance of the component. A medical professional embeds the medical device component into a bending tool. The medical professional then aligns an intended curve region of the medical device component within a bending region of the bending tool and imparts a curve in the bending region. Finally, the medical professional withdraws the medical device component from the bending tool, and utilizes the bent medical device component in the medical procedure. The system may be a kit comprising various medical device components for a particular medical procedure and a suitable bending tool for those components.

An atrial shunt regulation device, a braid tool and a braid method thereof. The left disk (1) and the right disk (2) of the atrial shunt regulation device are connected via the intermediate portion (3) as a single piece, and the left disk (1), the intermediate portion (3) and the right disk (2) are braided by a single braid wire (10). The ends of the braid wires are secured by one nut in the single-braid method, which reduces the number and size of the nuts and easily forms a cortical layer. The braid tool for braiding an atrial shunt regulation device comprises a cylinder braid body mold (20), the cylindrical braid body mold (20) includes positioning pins (21) that are evenly connected to an outer wall of the braid body mold. The braid method of the atrial shunt regulation device comprises braiding, thermoforming, braiding a binding-off wire, securing ends of wires by a nut, and thermoforming again. The braid method is easy, the process is easy, and the device can be made manually in small batches to reduce costs.

Several embodiments and methods are described for draining a lymphatic system for therapeutic purposes. The lymphatic draining can be performed by removal of fluid from the lymphatic system via a needle, a catheter, an access port, a reservoir, a shunt, or a combination of these devices. The drainage devices can be configured for use during only a single procedure or for reoccurring procedures.

The present technology relates to interatrial shunting systems and methods. In some embodiments, the present technology includes interatrial shunting systems that include a shunting element having a lumen extending therethrough that is configured to fluidly couple the left atrium and the right atrium when the shunting element is implanted in a patient. The system can also include an anchoring mechanism coupled to the shunting element and configured to secure the shunting element within the patients heart.

Systems, methods, and computer-readable media for providing a decision support solution to medical professionals to optimize medical care through data monitoring and feedback treatment are provided herein. In another embodiment, a computer-implemented method for modeling patient outcomes resulting from treatment in a specific medical area includes receiving patient-specific data associated with a patient, determining a plurality of possible patient states under which the patient can be categorized, a current patient state under which the patient can be categorized and determining probabilities of the patient transitioning from any of the possible patient states to every other possible patient state.

A device (100) for medical procedure localization and/or insertion that can be dimensionally adjusted for different patient sizes and properly aligned and stabilized using anatomical landmarks. The device (100) for medical procedure localization and/or insertion provides an adjustable template that indexes the site of interest at the intersection of a first axis or plane and a second axis or plane. An embodiment is disclosed in which a first axis is the axillary line through the patient's axilla (armpit) and iliac crest (pelvis), and a second axis is the patient's ideal horizontal nipple line. The intersection of the first and second axes is the 4th or 5th intercostal space, into which a needle and/or chest tube may be placed for decompression.

A medical catheter that includes an elongate main tube, the tube having an outer wall that surrounds an internal passage, branch tubes having an outer wall connected to the outer wall of the main tube which extend outward from the main tube in different respective directions and have one or more apertures passing through their outer wall to their internal passage to permit fluid to pass through the branch tubes and into the main tube in use. The branch tubes are arranged to be able to move towards each other to permit location of the catheter within the bore of a needle or needle-like apparatus and which return to their original outwards state when removed.

A method for manufacturing an inner drainage biomimetic stent for glaucoma. The inner drainage biomimetic stent for glaucoma comprises: a cylinder tube body with a hollow structure, and a plurality of straight tubes, provided inside the hollow structure of the tube body, for supporting a tube wall of the tube body. Proper placement of the inner drainage biomimetic stent for glaucoma can direct an aqueous humour to smoothly flow through an orifice expanded by the biomimetic stent, into Schlemm's canal. A collapsed Schlemm's canal is re-expanded by the flow of the aqueous humour to direct the aqueous humour to a collector canal, thereby lowering an intraocular pressure and achieving the goal of glaucoma treatment

Compositions and methods for inhibiting and interrupting biofilm formation, and for destabilizing established biofilms are provided, the novel compositions including polymeric resins and monomeric non-polymerizable and polymerizable resins. More particularly, the compositions and methods enable the protection and removal of biofilms from surfaces in the context of medical, consumer, domestic, food service, environmental and industrial applications, where the effects constitute beneficial and desirable biofilm attenuating activity.